HIV prevention at drug shops: awareness and attitudes among shop dispensers and young women about oral pre-exposure prophylaxis and the dapivirine ring in Shinyanga, Tanzania.
Adolescent girls
Dapivirine ring
Drug shops
HIV
HIV prevention
Long-acting PrEP
PrEP
Pre-exposure prophylaxis
Sub-Saharan Africa
Tanzania
Young women
Journal
AIDS research and therapy
ISSN: 1742-6405
Titre abrégé: AIDS Res Ther
Pays: England
ID NLM: 101237921
Informations de publication
Date de publication:
26 04 2021
26 04 2021
Historique:
received:
04
12
2020
accepted:
08
04
2021
entrez:
27
4
2021
pubmed:
28
4
2021
medline:
18
9
2021
Statut:
epublish
Résumé
HIV risk remains high among adolescent girls and young women (AGYW, ages 15-24) in Tanzania. Many AGYW experience stigma and provider bias at health facilities, deterring their use of HIV prevention services. Privately-owned drug shops, ubiquitous in many communities, may be an effective and accessible channel to deliver HIV prevention products to AGYW, including oral pre-exposure prophylaxis (PrEP) and the dapivirine vaginal ring. In July-August 2019, we enrolled 26 drug shops in Shinyanga, Tanzania in an ongoing study to create "girl-friendly" drug shops where AGYW can access HIV self-testing and contraception. At baseline, all shop dispensers were given basic information about oral PrEP and the dapivirine ring and were asked about their interest in stocking each. During the next 3-5 months, we surveyed AGYW (n = 56) customers about their interest in oral PrEP and the ring. Among dispensers, the median age was 42 years and 77% were female. Overall, 42% of dispensers had heard of a medication for HIV prevention. Almost all dispensers reported some interest in stocking oral PrEP (92%) and the dapivirine ring (96%). Most (85%) reported they would provide oral PrEP to AGYW who requested it. Among AGYW customers, the median age was 17 years; 29% of AGYW were married or had a steady partner and 18% had children. Only 20% of AGYW had heard of a medication to prevent HIV, yet 64% and 43% expressed some interest in using oral PrEP and the dapivirine ring, respectively, after receiving information about the products. PrEP interest was higher among AGYW who were partnered and had children. Despite low prior awareness of PrEP among shop dispensers and AGYW, we found high levels of interest in oral PrEP and the dapivirine ring in both groups. Community-based drug shops represent a promising strategy to make HIV prevention more accessible to AGYW.
Sections du résumé
BACKGROUND
HIV risk remains high among adolescent girls and young women (AGYW, ages 15-24) in Tanzania. Many AGYW experience stigma and provider bias at health facilities, deterring their use of HIV prevention services. Privately-owned drug shops, ubiquitous in many communities, may be an effective and accessible channel to deliver HIV prevention products to AGYW, including oral pre-exposure prophylaxis (PrEP) and the dapivirine vaginal ring.
METHODS
In July-August 2019, we enrolled 26 drug shops in Shinyanga, Tanzania in an ongoing study to create "girl-friendly" drug shops where AGYW can access HIV self-testing and contraception. At baseline, all shop dispensers were given basic information about oral PrEP and the dapivirine ring and were asked about their interest in stocking each. During the next 3-5 months, we surveyed AGYW (n = 56) customers about their interest in oral PrEP and the ring.
RESULTS
Among dispensers, the median age was 42 years and 77% were female. Overall, 42% of dispensers had heard of a medication for HIV prevention. Almost all dispensers reported some interest in stocking oral PrEP (92%) and the dapivirine ring (96%). Most (85%) reported they would provide oral PrEP to AGYW who requested it. Among AGYW customers, the median age was 17 years; 29% of AGYW were married or had a steady partner and 18% had children. Only 20% of AGYW had heard of a medication to prevent HIV, yet 64% and 43% expressed some interest in using oral PrEP and the dapivirine ring, respectively, after receiving information about the products. PrEP interest was higher among AGYW who were partnered and had children.
CONCLUSIONS
Despite low prior awareness of PrEP among shop dispensers and AGYW, we found high levels of interest in oral PrEP and the dapivirine ring in both groups. Community-based drug shops represent a promising strategy to make HIV prevention more accessible to AGYW.
Identifiants
pubmed: 33902623
doi: 10.1186/s12981-021-00343-1
pii: 10.1186/s12981-021-00343-1
pmc: PMC8074434
doi:
Substances chimiques
Anti-HIV Agents
0
Pharmaceutical Preparations
0
Pyrimidines
0
Dapivirine
TCN4MG2VXS
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
21Subventions
Organisme : NIMH NIH HHS
ID : R34 MH116804
Pays : United States
Organisme : National Institute of Mental Health (US)
ID : R34MH116804
Références
J Fam Plann Reprod Health Care. 2015 Jan;41(1):e2
pubmed: 25432866
J Am Pharm Assoc (2003). 2020 Jan - Feb;60(1):138-144
pubmed: 31405804
Perspect Sex Reprod Health. 2014 Dec;46(4):223-31
pubmed: 24786186
BMC Infect Dis. 2018 Oct 4;18(1):503
pubmed: 30286737
Sex Health. 2018 Nov;15(6):513-521
pubmed: 30408431
Int Fam Plan Perspect. 2006 Mar;32(1):6-16
pubmed: 16723297
Reprod Health Matters. 2006 May;14(27):109-18
pubmed: 16713885
AIDS. 2012 Oct 23;26(16):2059-67
pubmed: 22781227
Prog Community Health Partnersh. 2009 Summer;3(2):145-53
pubmed: 20208262
PLoS One. 2018 Dec 7;13(12):e0208167
pubmed: 30532210
Sex Health. 2018 Nov;15(6):556-561
pubmed: 30401342
PLoS One. 2016 Nov 8;11(11):e0164332
pubmed: 27824876
AIDS Patient Care STDS. 2019 May;33(5):207-213
pubmed: 31067124
Nat Med. 2020 May;26(5):655-664
pubmed: 32405065
Open Forum Infect Dis. 2019 Oct 1;6(10):
pubmed: 31412131
BMC Health Serv Res. 2011 Sep 17;11:220
pubmed: 21923927
AIDS Behav. 2020 Jul;24(7):2149-2162
pubmed: 31955361
PLoS One. 2018 Apr 27;13(4):e0196280
pubmed: 29702659
Am J Public Health. 2019 Jun;109(6):859-861
pubmed: 31067105
BMJ Open. 2019 Mar 20;9(3):e023272
pubmed: 30898799
Contraception. 2015 Aug;92(2):143-51
pubmed: 25869629
Int Perspect Sex Reprod Health. 2014 Dec;40(4):176-83
pubmed: 25565345